qPET – a quantitative extension of the Deauville scale to assess response in interim FDG-PET scans in lymphoma
Top Cited Papers
- 7 March 2014
- journal article
- research article
- Published by Springer Science and Business Media LLC in European Journal of Nuclear Medicine and Molecular Imaging
- Vol. 41 (7), 1301-1308
- https://doi.org/10.1007/s00259-014-2715-9
Abstract
No abstract availableKeywords
This publication has 39 references indexed in Scilit:
- Predictive value of interim 18F-FDG-PET/CT for event-free survival in patients with diffuse large B-cell lymphoma homogenously treated in a phase II trial with six cycles of R-CHOP-14 plus pegfilgrastim as first-line treatmentNuclear Medicine Communications, 2013
- Interim18F-FDG PET in Hodgkin Lymphoma: Would PET-Adapted Clinical Trials Lead to a Paradigm Shift?Journal of Nuclear Medicine, 2013
- Long‐term non‐cancer mortality in pediatric and young adult cancer survivors in FinlandPediatric Blood & Cancer, 2011
- 18F-FDG PET After 2 Cycles of ABVD Predicts Event-Free Survival in Early and Advanced Hodgkin LymphomaJournal of Nuclear Medicine, 2010
- Interim PET in lymphoma: a step towards standardizationEuropean Journal of Nuclear Medicine and Molecular Imaging, 2010
- Concordance between four European centres of PET reporting criteria designed for use in multicentre trials in Hodgkin lymphomaEuropean Journal of Nuclear Medicine and Molecular Imaging, 2010
- PET positive, PET negative, or PET peeve?Blood, 2010
- Interim positron emission tomography scan in Hodgkin lymphoma: definitions, interpretation rules, and clinical validationLeukemia & Lymphoma, 2009
- Positron emission tomography guided therapy of aggressive non-Hodgkin lymphomas – the PETAL trialLeukemia & Lymphoma, 2009
- Measuring Response with FDG-PET: Methodological AspectsThe Oncologist, 2009